Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer

NCT00616291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine

Sponsor

Baylor College of Medicine

Collaborators

[object Object]